# US Pharmaceutical Cartridges Market

> US Pharmaceutical Cartridges Market Research Report By Material (Glass, Plastic) and By Capacity (Below 5 ml, 5-50 ml, 51-250 ml, Above 250 ml) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.48%
- **2024:** $ 350 Million
- **2025:** $ 362.18 Million
- **2035:** $ 510 Million
- **Key Players:** Becton Dickinson (US), Gerresheimer (DE), Schott AG (DE), West Pharmaceutical Services (US), AptarGroup (US), Syringe Manufacturing (US), Medtronic (US), Fresenius Kabi (DE)

**Report ID:** MRFR/Pharma/15209-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-pharmaceutical-cartridges-market-16737

---

## Market Summary

## **US Pharmaceutical Cartridges Market Overview**

As per MRFR analysis, the US Pharmaceutical Cartridges Market Size was estimated at 326.35 (USD Million) in 2023. The US Pharmaceutical Cartridges Market Industry is expected to grow from 338.1(USD Million) in 2024 to 646.3 (USD Million) by 2035. The US Pharmaceutical Cartridges Market CAGR (growth rate) is expected to be around 6.067% during the forecast period (2025 - 2035).

### **Key US Pharmaceutical Cartridges Market Trends Highlighted**

The US Pharmaceutical Cartridges Market is witnessing significant trends driven by advances in healthcare technology and the increasing demand for efficient drug delivery systems. One of the key market drivers is the rising prevalence of chronic diseases in the US, prompting a shift towards the need for more effective treatment options.

This has fueled the development and adoption of prefilled cartridges, which enhance convenience and precision in medication administration. Moreover, the growing acceptance of biologics and specialty pharmaceuticals contributes to the accelerated use of cartridges, as these formulations often require specific delivery systems for optimal efficacy. Opportunities are notably expanding within the market due to the increasing focus on home-based healthcare.

As patients seek more autonomy in managing their health conditions, the demand for devices that enable self-administration of medication is on the rise. Additionally, the push for innovation in container closure systems presents a chance for manufacturers to create more secure, user-friendly drug delivery solutions. Enhanced safety features, reduced risks of contamination, and extended shelf-life are key attributes that can attract end-users.

Recent trends indicate a shift towards environmentally sustainable packaging in the US market. Healthcare providers and consumers are increasingly aware of the environmental impact of pharmaceuticals, leading to a demand for cartridges made from recyclable or biodegradable materials. Furthermore, regulatory measures and guidelines from US health authorities encourage manufacturers to comply with new standards regarding drug safety and efficacy, ultimately influencing design and development in this sector. As technology advances and patient preferences evolve, the US Pharmaceutical Cartridges Market continues to adapt and thrive in response to these dynamics.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Pharmaceutical Cartridges Market Drivers**

### **Increasing Demand for Biologics**

The escalating demand for biologics in the United States is significantly driving the growth of the US Pharmaceutical Cartridges Market Industry. Reports from the Biotechnology Innovation Organization indicate that the U.S. biotechnology sector had approximately 400 biologics approved by the Food and Drug Administration as of 2021, with growth expected to continue at a rate of 12% annually.

The increasing reliance on biologics for treating chronic conditions such as cancer, diabetes, and autoimmune diseases underscores the necessity for efficient delivery systems, such as cartridges, which facilitate the precise administration of these complex medications. Major pharmaceutical companies like Amgen and Genentech are investing heavily in R&D for novel biologic therapies, further amplifying the market's evolution.

This trend is expected to accelerate cartridge adoption, as these delivery systems are integral for ensuring drug stability and efficacy in biologic administration, translating to robust market growth in the upcoming years.

### **Technological Advancements in Injection Systems**

Technological innovations in drug delivery systems are set to enhance the US **[Pharmaceutical Cartridges Market](../../../reports/pharmaceutical-cartridges-market-11679)** Industry. Recent advancements in needle-free injection systems have seen stakeholders like BD (Becton, Dickinson and Company) commercializing new devices that improve patient comfort and adherence. These technologies offer precise dosing and reduced pain, which is particularly important for patients requiring frequent injections.

The National Center for Biotechnology Information has reported that innovative injection technologies can enhance patient compliance rates by up to 35%. As the U.S. population becomes more health-conscious and familiar with these advancements, the market is witnessing a substantial uptick that supports overall growth.

### **Rising Incidence of Diabetes and Obesity**

The alarming rise in diabetes and obesity rates in the U.S. is a prominent driver for the US Pharmaceutical Cartridges Market Industry. According to the Centers for Disease Control and Prevention, more than 34 million Americans have diabetes, and approximately 94.3 million adults are classified as obese. This surge creates a significant demand for effective management solutions, including insulin delivery systems that utilize pharmaceutical cartridges.

Companies like Novo Nordisk and Sanofi are creating user-friendly cartridge-based insulin pens that cater to this growing demographic. The anticipation of managing chronic diseases through improved medication delivery systems will undoubtedly propel the market's expansion in the coming years.

## **US Pharmaceutical Cartridges Market Segment Insights**

### **Pharmaceutical Cartridges Market Material Insights**

The US Pharmaceutical Cartridges Market, particularly within the Material segment, showcases vital characteristics that underline its robustness and growth potential. The overall landscape of the market reflects an increasing demand driven by advancements in delivery systems for therapeutics, resulting in a significant inclination towards materials that ensure optimal safety and effectiveness.

The Material segment is primarily characterized by the use of Glass and Plastic, each holding its own importance and appeal in the pharmaceutical packaging sector. Glass is renowned for its excellent barrier properties, chemical resistance, and ability to maintain product integrity over extended periods, making it a popular choice for sensitive medications like biologics and vaccines.

On the other hand, Plastic offers several practical benefits, including lightweight construction and cost-effectiveness, facilitating easier handling and transportation. The versatility of Plastic allows it to be molded into intricate shapes essential for various drug delivery methods. The segmentation of the US Pharmaceutical Cartridges Market into Glass and Plastic not only emphasizes material properties but also reflects broader industry trends, such as sustainability concerns driving research and development towards more eco-friendly options.

With regulatory bodies and healthcare professionals increasingly advocating for enhanced safety standards and effective drug delivery mechanisms, the demand for high-quality materials is solidifying. Additionally, the ongoing research into innovative manufacturing techniques is anticipated to further refine the material characteristics in use, aiming for improvements in product reliability and patient compliance.

As such, this bifurcation is crucial as it not only aids in understanding market dynamics but also serves as a guide for future innovations. The material choices directly influence the market growth trajectories, serving different therapeutic needs and influencing production practices within the industry, which is an integral consideration for stakeholders engaging in the US Pharmaceutical Cartridges Market. Overall, the significant focus on Glass and Plastic illustrates the growing interplay between material science and pharmaceutical applications, where each continues to adapt in response to evolving market demands.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Pharmaceutical Cartridges Market Capacity Insights**

The Capacity segment of the US Pharmaceutical Cartridges Market showcases a diverse range of sizes, which are critical for accommodating various pharmaceutical applications. The sub-segment of Below 5 ml is particularly significant as it caters to precise dosages needed for potent medications, especially in areas like vaccines and biologics.

On the other hand, the 5-50 ml range is ideal for a broad spectrum of drug formulations, striking a balance between the requirements of precision and volume. Larger capacities, such as 51-250 ml and Above 250 ml, are essential for bulk pharmaceutical production and are increasingly adopted for larger treatment regimens, particularly in chronic disease management.

The growth drivers for this segment include the rising demand for self-administered therapies, and advancements in manufacturing technology pushing for more efficient drug delivery systems. Challenges such as stringent regulatory requirements may impact innovation; however, opportunities remain robust, particularly as the healthcare industry shifts towards personalized medicine and innovative delivery methods. It is evident that the Capacity segment plays a pivotal role in the US Pharmaceutical Cartridges Market, aligning with the overall trend towards efficient and effective patient care solutions.

## **US Pharmaceutical Cartridges Market Key Players and Competitive Insights**

The competitive landscape of the US Pharmaceutical Cartridges Market is characterized by rapid advancements in technology, increasing demand for biologics, and a growing emphasis on patient-centric drug delivery systems. As healthcare professionals and patients increasingly seek more efficient and reliable means of medication delivery, pharmaceutical cartridges have gained significant traction. Understanding competitive insights in this market is crucial for stakeholders as they navigate opportunities and challenges imposed by evolving regulations, technological innovations, and consumer expectations. Companies are continuously striving to enhance their product offerings and regulatory compliance to secure their position in this dynamic market.

Schott AG has established a strong foothold in the US Pharmaceutical Cartridges Market by leveraging its innovative technologies and deep expertise in glass manufacturing. The company is recognized for its high-quality pharmaceutical packaging solutions, particularly in prefillable syringes and cartridges. Schott AG benefits from an extensive global presence and a well-established reputation for quality and safety in the pharmaceutical sector, which allows it to form strategic partnerships and collaborations within the region.

The company’s commitment to research and development has led to breakthroughs in product features such as improved stability for sensitive biologics, making its cartridges a preferred choice among pharmaceutical companies in the US. Furthermore, Schott AG’s emphasis on customer service and tailored solutions has solidified its competitive advantage, enhancing its brand loyalty in this niche market.

Novartis plays a significant role in the US Pharmaceutical Cartridges Market with a diverse range of injectable medications utilized in chronic and acute care settings. The company's key products offered in cartridge formats reflect its strengths in pharmaceuticals that cater to various therapeutic areas, such as oncology, immunology, and ophthalmology. Novartis has maintained a robust presence in the market through consistent investments in research and development, focusing on enhancing the efficiency and effectiveness of its drug delivery systems.

Notably, the company has engaged in strategic mergers and acquisitions to expand its portfolio and capabilities in the pharmaceutical cartridge sector. This ensures that Novartis remains competitive, able to adapt to market demands and capitalize on the growing trend of biologic drug formulations requiring advanced delivery mechanisms.

### **Key Companies in the US Pharmaceutical Cartridges Market Include**

## **US Pharmaceutical Cartridges Market Industry Developments**

The US Pharmaceutical Cartridges Market has been witnessing significant advancements recently, particularly with companies like Pfizer and Merck focusing on enhancing their product offerings through innovative cartridge designs. In August 2023, Eli Lilly announced a strategic partnership with Medtronic to collaborate on integrated delivery systems leveraging their pharmaceutical cartridges for chronic disease management.

Additionally, AstraZeneca is pushing forward with its expansion in the US, intending to increase production capacity for injectable pharmaceuticals, which has a direct impact on the cartridges needed for distribution. Recent mergers include the acquisition of Catalent, a key player in the market, by Thermo Fisher Scientific, announced in July 2023, aiming to bolster their manufacturing capabilities in pharmaceutical cartridges.

The market is also buoyed by the rising demand for biologics and specialty medications, pushing companies such as Amgen and GlaxoSmithKline to expand their cartridge solutions. The growth momentum is further emphasized, with reports showing a notable increase in market valuation driven by technological innovations and strategic partnerships over the last 2-3 years, especially highlighted in developments from mid-2021 onwards.

## **US Pharmaceutical Cartridges Market Segmentation Insights**

### **Pharmaceutical Cartridges Market Material Outlook**

### **Pharmaceutical Cartridges Market Capacity Outlook**

## Market Drivers

### Rising Demand for Biologics

The pharmaceutical cartridges market experiences a notable surge in demand due to the increasing prevalence of biologics. These complex drugs, derived from living organisms, require precise delivery mechanisms, which pharmaceutical cartridges provide. The market for biologics is projected to reach approximately $300 billion by 2025, indicating a robust growth trajectory. As healthcare providers seek efficient and reliable methods for administering biologics, the pharmaceutical cartridges market is poised to benefit significantly. This trend is further supported by the growing number of biologic therapies approved by regulatory bodies, which enhances the need for specialized delivery systems. Consequently, the pharmaceutical cartridges market is likely to expand as manufacturers innovate to meet the specific requirements of biologic formulations.

### Shift Towards Home Healthcare

The pharmaceutical cartridges market is influenced by the increasing shift towards home healthcare solutions. As patients prefer receiving treatments in the comfort of their homes, the demand for user-friendly and efficient drug delivery systems rises. Pharmaceutical cartridges facilitate self-administration of medications, which aligns with the growing trend of patient-centric care. The home healthcare market is expected to grow at a CAGR of around 8% through 2025, further driving the need for innovative delivery systems. This shift not only enhances patient compliance but also reduces healthcare costs, making the pharmaceutical cartridges market an essential component of the evolving healthcare landscape. Manufacturers are likely to focus on developing cartridges that cater to the specific needs of home healthcare, thereby expanding their market presence.

### Technological Integration in Drug Delivery

The pharmaceutical cartridges market is witnessing a transformation due to the integration of advanced technologies in drug delivery systems. Innovations such as smart cartridges equipped with sensors and connectivity features are enhancing the efficiency and effectiveness of medication administration. These technologies allow for real-time monitoring of dosage and adherence, which is crucial for patient outcomes. The market for smart drug delivery systems is expected to grow significantly, potentially reaching $50 billion by 2025. This technological advancement not only improves patient safety but also provides healthcare professionals with valuable data for better management of treatment plans. As a result, the pharmaceutical cartridges market is likely to see increased investment in research and development to create next-generation delivery systems.

### Increased Focus on Chronic Disease Management

The pharmaceutical cartridges market is significantly impacted by the rising focus on chronic disease management. With chronic diseases such as diabetes and cardiovascular conditions on the rise, there is an increasing need for effective drug delivery systems. Pharmaceutical cartridges offer precise dosing and ease of use, which are critical for managing these long-term conditions. The chronic disease management market is projected to reach $200 billion by 2025, indicating a substantial opportunity for the pharmaceutical cartridges market. As healthcare providers emphasize the importance of adherence to treatment regimens, the demand for reliable delivery systems is likely to grow. This trend suggests that the pharmaceutical cartridges market will continue to evolve, with manufacturers developing solutions tailored to the needs of chronic disease patients.

### Growing Regulatory Support for Advanced Delivery Systems

The pharmaceutical cartridges market benefits from growing regulatory support aimed at advancing drug delivery systems. Regulatory agencies are increasingly recognizing the importance of innovative delivery methods in improving patient outcomes. This support is reflected in streamlined approval processes for new delivery technologies, which encourages manufacturers to invest in research and development. The market for advanced drug delivery systems is projected to grow at a CAGR of approximately 7% through 2025, driven by favorable regulatory environments. As regulations evolve to accommodate new technologies, the pharmaceutical cartridges market is likely to expand, with manufacturers developing compliant and effective delivery solutions that meet the needs of healthcare providers and patients alike.

## Future Outlook

The [Pharmaceutical Cartridges Market](https://www.marketresearchfuture.com/reports/pharmaceutical-cartridges-market-11679) is projected to grow at a 3.48% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for precision medicine, and regulatory support.

**New opportunities:**

- Development of smart cartridges with IoT integration for real-time monitoring.
- Expansion into personalized medicine through customizable cartridge solutions.
- Partnerships with telehealth platforms for remote patient management solutions.

By 2035, the market is expected to achieve robust growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Material: Glass (Largest) vs. Plastic (Fastest-Growing)

In the US pharmaceutical cartridges market, the material segment is primarily dominated by glass, which accounts for a significant share due to its robustness and resistance to chemical interaction. Glass cartridges are preferred for their ability to maintain the integrity of pharmaceuticals, leading to higher market penetration. On the other hand, plastic cartridges are gaining traction, driven by their lightweight characteristics and lower manufacturing costs, which appeal to a broader range of applications and manufacturers.

The growth trends in this segment reveal a dynamic shift, with plastic cartridges emerging as the fastest-growing segment. This change is primarily attributed to technological innovations in polymer materials that enhance the functionality of plastic cartridges, making them suitable for a wider variety of pharmaceutical products. Demand for cost-effective and flexible packaging solutions further fuels this growth, indicating a shift in consumer preferences toward plastic solutions for efficient manufacturing processes.

Material: Glass (Dominant) vs. Plastic (Emerging)

Glass cartridges are established as the dominant choice in the US pharmaceutical cartridges market due to their superior barrier properties, which protect the contents from external factors. Their inert nature prevents chemical reactions, making glass ideal for storing sensitive pharmaceuticals. Conversely, plastic cartridges, while still considered emerging, are increasingly recognized for their adaptability and cost savings. Advancements in polymer technology are enabling plastic materials to match the performance of glass, thus attracting pharmaceutical companies aiming to reduce packaging costs while ensuring product safety. This shift indicates a growing acceptance of plastic as a viable alternative, leading to a more competitive landscape within the market.

### By Capacity: 5-50 ml (Largest) vs. 51-250 ml (Fastest-Growing)

The US pharmaceutical cartridges market displays a diverse capacity segment distribution. The 5-50 ml capacity category retains the largest market share, appealing to a wide range of applications such as vaccines and injectable medications. In contrast, segments like Below 5 ml and Above 250 ml show relatively smaller shares, catering to niche markets. 51-250 ml cartridges, however, have begun to gain traction, driven by the increasing demand for biologics and larger dose medications.

Growth trends in this segment indicate a shift towards the 51-250 ml category, which is identified as the fastest-growing segment. The demand for larger volumes is fueled by the rise in chronic diseases and biologics, necessitating efficient drug delivery systems. Innovation in cartridge technology and sustainable practices also contribute to this development, pushing manufacturers to adapt their offerings to meet evolving healthcare needs.

5-50 ml (Dominant) vs. 51-250 ml (Emerging)

The 5-50 ml segment of the US pharmaceutical cartridges market is characterized by its dominance, serving as the go-to choice for various injectable therapies, including vaccines. Its established presence in the market ensures a steady demand, driven by consistent usage in hospital and outpatient settings. Conversely, the 51-250 ml segment is gaining momentum as an emerging choice, particularly in the production of biologics and large-volume injectable medications. This growth is driven by innovations in drug formulations and delivery mechanisms, attracting interest from both pharmaceutical companies and healthcare providers aiming for efficiency in treatment delivery.

## Competitive Benchmarking

The pharmaceutical cartridges market is characterized by a dynamic competitive landscape, driven by innovation, regulatory compliance, and the increasing demand for advanced drug delivery systems. Key players such as Becton Dickinson (US), West Pharmaceutical Services (US), and Gerresheimer (DE) are at the forefront, each adopting distinct strategies to enhance their market positioning. Becton Dickinson (US) focuses on expanding its product portfolio through technological advancements, while West Pharmaceutical Services (US) emphasizes strategic partnerships to bolster its manufacturing capabilities. Gerresheimer (DE) appears to be concentrating on sustainability initiatives, which may resonate well with environmentally conscious consumers and regulatory bodies alike.The market structure is moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing to optimize supply chains and reduce lead times. This tactic not only enhances operational efficiency but also aligns with the growing trend of regional sourcing, which is becoming essential in the current economic climate. The collective influence of these key players shapes a competitive environment where innovation and responsiveness to market demands are paramount.

In October  Becton Dickinson (US) announced the launch of a new line of prefilled syringes designed to improve patient safety and reduce medication errors. This strategic move underscores the company's commitment to innovation in drug delivery systems, potentially positioning it as a leader in the market. The introduction of these syringes may enhance Becton Dickinson's competitive edge by addressing critical healthcare challenges and aligning with regulatory expectations for safety.

In September  West Pharmaceutical Services (US) entered into a partnership with a leading biotechnology firm to develop customized drug delivery solutions. This collaboration is likely to enhance West's capabilities in providing tailored solutions for complex biologics, thereby expanding its market reach. Such strategic alliances may facilitate knowledge sharing and resource optimization, which are crucial in a rapidly evolving market.

In August  Gerresheimer (DE) unveiled its new sustainability strategy aimed at reducing carbon emissions by 30% by 2030. This initiative not only reflects a growing trend towards environmental responsibility but also positions Gerresheimer favorably among stakeholders who prioritize sustainability. The strategic importance of this move lies in its potential to attract new customers and retain existing ones who are increasingly concerned about the environmental impact of their suppliers.

As of November  the competitive trends in the pharmaceutical cartridges market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in manufacturing processes. Strategic alliances are becoming more prevalent, enabling companies to leverage complementary strengths and enhance their innovation capabilities. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and sustainable practices. This shift may redefine market dynamics, compelling companies to innovate continuously to maintain their competitive positions.

## Recent News & Developments

The US Pharmaceutical Cartridges Market has been witnessing significant advancements recently, particularly with companies like Pfizer and Merck focusing on enhancing their product offerings through innovative cartridge designs. In August 2023, Eli Lilly announced a strategic partnership with Medtronic to collaborate on integrated delivery systems leveraging their pharmaceutical cartridges for chronic disease management.

Additionally, AstraZeneca is pushing forward with its expansion in the US, intending to increase production capacity for injectable pharmaceuticals, which has a direct impact on the cartridges needed for distribution. Recent mergers include the acquisition of Catalent, a key player in the market, by Thermo Fisher Scientific, announced in July 2023, aiming to bolster their manufacturing capabilities in pharmaceutical cartridges.

The market is also buoyed by the rising demand for biologics and specialty medications, pushing companies such as Amgen and GlaxoSmithKline to expand their cartridge solutions. The growth momentum is further emphasized, with reports showing a notable increase in market valuation driven by technological innovations and strategic partnerships over the last 2-3 years, especially highlighted in developments from mid-2021 onwards.

## Report Scope

| MARKET SIZE 2024 | 350.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 362.18(USD Million) |
| MARKET SIZE 2035 | 510.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.48% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Becton Dickinson (US), Gerresheimer (DE), Schott AG (DE), West Pharmaceutical Services (US), AptarGroup (US), Syringe Manufacturing (US), Medtronic (US), Fresenius Kabi (DE) |
| Segments Covered | Material, Capacity |
| Key Market Opportunities | Integration of advanced materials and automation in pharmaceutical cartridges manufacturing enhances efficiency and product quality. |
| Key Market Dynamics | Rising demand for advanced drug delivery systems drives innovation in the pharmaceutical cartridges market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US pharmaceutical cartridges market in 2024?**
A: The market valuation was $350.0 Million in 2024.

**Q: What is the projected market valuation for the US pharmaceutical cartridges market in 2035?**
A: The projected valuation for 2035 is $510.0 Million.

**Q: What is the expected CAGR for the US pharmaceutical cartridges market during the forecast period 2025 - 2035?**
A: The expected CAGR is 3.48% during the forecast period 2025 - 2035.

**Q: Which materials dominate the US pharmaceutical cartridges market?**
A: The market segments include Glass cartridges valued at $150.0 - $220.0 Million and Plastic cartridges valued at $200.0 - $290.0 Million.

**Q: What are the capacity segments for pharmaceutical cartridges in the US market?**
A: Capacity segments include Below 5 ml ($50.0 - $70.0 Million), 5-50 ml ($120.0 - $180.0 Million), 51-250 ml ($130.0 - $200.0 Million), and Above 250 ml ($50.0 - $70.0 Million).

**Q: Who are the key players in the US pharmaceutical cartridges market?**
A: Key players include Becton Dickinson, Gerresheimer, Schott AG, West Pharmaceutical Services, AptarGroup, Syringe Manufacturing, Medtronic, and Fresenius Kabi.

**Q: How does the market for pharmaceutical cartridges appear to be evolving?**
A: The market appears to be growing steadily, with a projected increase in valuation from $350.0 Million in 2024 to $510.0 Million by 2035.

**Q: What factors might influence the growth of the US pharmaceutical cartridges market?**
A: Factors influencing growth may include advancements in technology, increasing demand for injectable drugs, and the expansion of healthcare services.

**Q: What is the significance of the capacity segment 51-250 ml in the market?**
A: The 51-250 ml capacity segment is projected to be valued between $130.0 - $200.0 Million, indicating a robust demand for mid-range cartridge sizes.

**Q: How do the valuations of Glass and Plastic cartridges compare?**
A: Plastic cartridges are valued higher at $200.0 - $290.0 Million compared to Glass cartridges, which are valued at $150.0 - $220.0 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-pharmaceutical-cartridges-market-16737*